Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMortgage Advice Bureau Regulatory News (MAB1)

Share Price Information for Mortgage Advice Bureau (MAB1)

Share Price is delayed by 15 minutes
Get Live Data
525.00    0.00 (0.00%)
Bid:
523.00
Ask:
527.00
Spread: 4.00 (0.765%)
Market Cap: £302.10m
MAB1 Live PriceLast checked at - London Stock Exchange

Intraday Mortgage Advice Bureau Share Chart

Related Party Transaction

29 May 2024 07:00

RNS Number : 1722Q
Mortgage Advice Bureau (Hldgs) PLC
29 May 2024
 

29 May 2024

Mortgage Advice Bureau (Holdings) plc ("MAB" or "the Company")

Purchase of remaining 20% of First Mortgage Direct Limited and associated Issue of Equity

Mortgage Advice Bureau (Holdings) plc (AIM:MAB1.L) announces that further to the acquisition of 80% of First Mortgage Direct Limited ("First Mortgage") on 2 July 2019, MAB has now exercised its option to acquire the remaining 20% of the entire issued share capital of First Mortgage for a consideration of £9.35 million (the "Consideration") from Ian McGrail, Managing Director of First Mortgage.

Under the terms of the put and call option agreement, the Company has exercised its discretion to satisfy 25% of the Consideration in cash, being £2.34 million, and 75% of the Consideration, being £7.01 million, by the issue of new ordinary shares in the Company using an agreed formula. The Company has therefore issued 804,754 Ordinary Shares of 0.1p each in the capital of the Company (the "New Ordinary Shares").

Application has been made for the New Ordinary Shares to be admitted to trading on AIM ("Admission"). It is expected that Admission will become effective and trading will commence at 8:00am on 3 June 2024. The New Ordinary Shares will rank pari passu in all respects with the Company's existing ordinary shares in issue.

Following Admission, the total number of ordinary shares in the Company with voting rights in issue will be 57,956,789. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

First Mortgage made a profit before tax of £5.4 million in the year ended 31 December 2023, and had net assets of £9.3 million as at 31 December 2023. As Ian McGrail is a director of First Mortgage, the acquisition of the remaining 20% of First Mortgage constitutes a related party transaction under the AIM Rules. The Directors of MAB consider, having consulted with its nominated adviser, that the terms of the transaction are fair and reasonable insofar as its shareholders are concerned. Ian McGrail will continue to be Managing Director of First Mortgage. This transaction is expected to be earnings enhancing for MAB.

Ben Thompson, Deputy CEO, commented:

"Acquiring an 80% shareholding in First Mortgage in 2019 was strategically important to MAB at the time, enabling us to grow our expertise in specific market specialisms such as new build, and accelerate our overall market share as a Group. Despite the various challenges we all faced together over the last five years, the business has grown substantially in size and in profitability and has become even more important to MAB. We are therefore really pleased to have now acquired the final 20% shareholding from Ian McGrail. Importantly, we are delighted that Ian has decided to commit to stay on as Managing Director and take First Mortgage further over the coming years, having done such an excellent job of the last five, and indeed the years prior to that."

Enquiries:

Mortgage Advice Bureau (Holdings) plc

  +44 (0)1332 525007

Peter Brodnicki, Chief Executive Officer

Ben Thompson, Deputy Chief Executive Officer

Emilie McCarthy, Chief Financial Officer

 

Nominated Adviser and Joint Broker:

Deutsche Numis

Stephen Westgate / Giles Rolls

 

 

 +44 (0)20 7260 1000

Joint Broker:

Peel Hunt LLP

Andrew Buchanan / Oliver Jackson / Rob Parker

 

+44 (0) 20 7418 8900

Media Enquiries: 

investorrelations@mab.org.uk

 

This announcement contains inside information as defined in Article 7 of Regulation (EU) no 596/2014 of the European Parliament and of the Council of 16 April 2014 on Market Abuse (Market Abuse Regulation) as retained as part of UK law by virtue of the European Union (Withdrawal) Act 2018 as amended.

Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBVLLLZELLBBD
Date   Source Headline
8th Jun 202611:22 amRNSDirector/PDMR Shareholding
1st Jun 20263:59 pmRNSDirectors' Shareholdings and PDMR notification
1st Jun 20262:53 pmRNSDirectorate change
21st May 20269:15 amRNSDirector/PDMR Shareholding
21st May 20267:00 amRNSResult of AGM
20th May 20267:00 amRNSAGM Trading Statement
14th May 20269:12 amRNSHolding(s) in Company
1st May 202612:41 pmRNSDirector/PDMR Shareholding
1st May 20268:00 amRNSReadmission - Mortgage Advice Bureau (Hldgs) PLC
1st May 20267:00 amRNSAdmission to trading on the Main Market
28th Apr 20266:00 pmRNSMortgage Advice Bureau
27th Apr 202612:00 pmRNSPublication of Prospectus and Trading Update
24th Apr 20267:00 amRNSTransaction in Own Shares
23rd Apr 20265:14 pmRNSHolding(s) in Company
21st Apr 20265:37 pmRNSNotice of AGM
21st Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20264:49 pmRNSHolding(s) in Company
16th Apr 20263:03 pmRNSDirector/PDMR Shareholding
14th Apr 20267:00 amRNSTransaction in Own Shares
14th Apr 20267:00 amRNSAcquisition of HomeOwners Alliance Ltd
13th Apr 202610:32 amRNSDirectors' Shareholdings and PDMR notification
10th Apr 202610:29 amRNSStandard form for notification of major holdings
10th Apr 202610:25 amRNSStandard form for notification of major holdings
7th Apr 20267:00 amRNSTransaction in Own Shares
31st Mar 20262:23 pmRNSStandard form for notification of major holdings
31st Mar 20267:00 amRNSLaunch of Share Buyback Programme
31st Mar 20267:00 amRNSUpdate on Move to the Main Market
30th Mar 20263:33 pmRNSStandard form for notification of major holdings
23rd Mar 20262:47 pmRNSBlock Listing Interim Review
18th Mar 20265:11 pmRNSDirector/PDMR Shareholding
17th Mar 202611:52 amRNSNotification of Holding(s) in Company
17th Mar 20267:00 amRNSFinal Results
17th Mar 20267:00 amRNSFinal Results
3rd Mar 202612:15 pmRNSDirectors' Shareholdings and PDMR notification
26th Feb 20263:46 pmRNSTR-1: Notification of major holdings
24th Feb 20267:00 amRNS-RNotice of Final Results 2025 Investor Presentation
17th Feb 202611:13 amRNSDirectors' Shareholdings and PDMR notification
11th Feb 20263:19 pmRNSNotification of major holdings
6th Feb 20262:39 pmRNSChanges to concert party
2nd Feb 20264:40 pmRNSDirectors' Shareholdings and PDMR notification
2nd Feb 20267:00 amRNSPure Protection Market Study Update
28th Jan 20267:00 amRNSCapital Markets Update
27th Jan 20263:38 pmRNSDirectors' Shareholdings and PDMR notification
22nd Jan 20267:00 amRNSTrading Update
5th Jan 20264:47 pmRNSTotal Voting Rights
23rd Dec 20254:25 pmRNSIssuance of Shares and Total Voting Rights
23rd Dec 20254:25 pmRNSIssuance of Shares and Total Voting Rights
17th Dec 202512:01 pmRNSDirector/PDMR Shareholding
11th Dec 20257:00 amRNSDirectorate changes
4th Dec 20259:25 amRNSStandard form for notification of major holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.